RSMDF
What one share of ResMed holds
Surgical and Medical Instruments and Apparatus
We are a global leader in digital health and cloud-connected medical devices. We design innovative technology to empower people to live happier, healthier lives. Our artificial intelligence, or AI, powered digital health solutions, cloud-connected devices and intelligent software are designed to make home healthcare more personalized, accessible and effective.
ResMed’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $38.71 |
|---|---|
| Profit | $10.43 |
| Capex (buildings and equipment) | $1.07 |
| Free cash flow | $11.29 |
| Dividends | $2.40 |
| Cash and investments | $10.19 |
| Debt | $4.57 |
| Book value | $45.66 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $14.51 | $2.40 | $0.44 | $2.47 | $1.32 | $13.79 |
| 2018 | $16.25 | $2.19 | $0.43 | $3.07 | $1.40 | $14.43 |
| 2019 | $18.04 | $2.80 | $0.48 | $2.70 | $1.48 | $14.42 |
| 2020 | $20.30 | $4.27 | $0.65 | $4.85 | $1.56 | $17.23 |
| 2021 | $21.83 | $3.24 | $0.70 | $4.33 | $1.56 | $19.81 |
| 2022 | $24.33 | $5.30 | $0.92 | $1.47 | $1.68 | $22.95 |
| 2023 | $28.64 | $6.09 | $0.81 | $3.89 | $1.76 | $28.08 |
| 2024 | $31.75 | $6.92 | $0.67 | $8.82 | $1.92 | $33.11 |
| 2025 | $34.93 | $9.51 | $0.61 | $11.28 | $2.12 | $40.77 |
| 2026 | $38.71 | $10.43 | $1.07 | $11.29 | $2.40 | $45.66 |